Johnson and Johnson vaccine sidelined….’
Astra-Zenca vaccine sidelined….
A booster shot every year for the rest of your life?
US stock piling vaccines while other countries beg for more….
Vaccine patents vs making money off them…
J & J vaccine blood clots?
Governor’s rushing to re-open their states…
Hard efforts to reopen schools….
And to top all this off?
Varient questions unanswered …..
The president has earned high marks for his pandemic response thus far from health experts and the public alike. A Monmouth poll this week found that 62 percent of adults say Biden has done a good job handling the coronavirus pandemic, a figure that is higher than the 54 percent who approve of Biden’s job as president overall less than 100 days into his presidency.
But the current setbacks could pose some challenges to those figures.
“I don’t think it reflects on Biden specifically, but it may slow the overall effort to get the country back up and running and it may add fuel to the skepticism that many Americans still have about the vaccine,” said a Democratic strategist of the developments with the Johnson & Johnson vaccine.
While the Johnson & Johnson delay will not disrupt the supply of vaccine doses to the country, it denies the nation the only approved shot that can be delivered in one dose and a vaccine that is easier to store than the Pfizer and Moderna vaccines.
This could make it harder to get vaccines to more vulnerable populations and left some public health officials criticizing the decision, arguing it would lead to more vaccine hesitancy and slow the recovery….
The pace of daily vaccinations has steadily increased over the past several weeks, with officials announcing this week that the U.S. is now averaging 3 million coronavirus vaccine shots everyday, with 3.5 million doses administered on Wednesday. More than 100 million Americans have received at least one dose of vaccine to date.
Still, vaccine hesitancy was an issue even before the unwelcome news. Monmouth found that 21 percent of U.S. adults say they are unlikely to get a vaccine, down from 24 percent in March but still high.
Michael Osterholm, an epidemiologist who served on Biden’s COVID-19 advisory board during the transition, acknowledged that the decision to pause the vaccine could create more hesitancy toward the Johnson & Johnson vaccine in particular but described it as a necessary step in demonstrating transparency around the vaccine process to the public.
Health experts expressed confidence that by summer, through a combination of warmer weather and a more widely vaccinated public, the country will likely have moved past the current spike in cases…
But health experts describe the hesitancy issue as a complex challenge, one that requires officials to understand the rationale of each group that has expressed reluctance and address concerns independently.
“When you start looking at all the different parties that may have reluctance to get vaccinations, there’s not one real answer. Part of the challenge is you can’t just put a billboard up that says get vaccinated,” said Osterholm….